Insilico Medicine, a clinical-stage generative AI drug discovery company, has announced a multi-target strategic alliance with Bora Pharmaceuticals, a global...

In a groundbreaking advancement for targeted drug delivery, an international team of scientists has successfully combined asymmetric-flow field-flow fractionation (AF4)...

A groundbreaking meta-analysis has emerged, shedding unprecedented light on the pharmacological strategies employed to combat muscular degeneration in Duchenne muscular...

In the relentless pursuit of new therapeutics, structure-based virtual screening (VS) through molecular docking has cemented its role as a...

In a groundbreaking advancement for pharmaceutical innovation, Insilico Medicine and SK Biopharmaceuticals have announced an ambitious AI-powered collaboration targeting neuroimmune...

The International Society for Stem Cell Research (ISSCR) has announced a pivotal advancement in the realm of biomedical research with...

In a groundbreaking advancement that may revolutionize the treatment of esophageal disorders, engineers at MIT have developed an innovative gel-like...

In a groundbreaking multicenter study that challenges conventional therapeutic strategies for chronic psoriasis, researchers from Radboud University Medical Center and...

In an era when artificial intelligence continues reshaping the landscape of biomedical research, a new study promises to transform drug...

Cambridge, MA — May 29, 2025 — Insilico Medicine, a trailblazer in AI-driven drug discovery, is gearing up to spotlight...